Literature DB >> 22872462

Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases.

A Stecco1, M Lombardi, L Leva, M Brambilla, E Negru, S Delli Passeri, A Carriero.   

Abstract

PURPOSE: This study was done to determine the diagnostic value of whole-body magnetic resonance using diffusion-weighted imaging with background suppression (WB-DWIBS) for detecting bone metastases compared with whole-body bone scintigraphy (WB-BS).
MATERIALS AND METHODS: Twenty-three patients with solid tumours underwent both WB-DWIBS imaging and WBBS. A nuclear medicine specialist interpreted WB-BS images and two blinded radiologists, first independently and then jointly, interpreted the WB-DWIBS images by completing a reading grid categorising the skeletal segments. Cohen's k statistic was used to determine interobserver agreement in reading the WB-DWIBS images and the agreement between WB-BS and WB-DWIBS. Sensitivity and specificity were calculated per patient and per lesion.
RESULTS: Interobserver agreement in reading the WBDWIBS images was substantial or good, with κ=0.68. Analysis of agreement between the nuclear physician's and the radiologists' readings provided κ=0.87 [95% confidence interval (CI)=0.76-0.98)] Per-lesion analysis gave a sensitivity of 80% (95% CI=75-85) and a specificity of 98.2% (95% CI=96.5-99.8).
CONCLUSIONS: We found a good level of interobserver agreement for the WB-DWIBS images and an excellent level of agreement in the subjective judgement of presence or absence of disease between WB-BS and WB-DWIBS after consensual double reading. WB-DWIBS has the same specificity as WB-BS in detecting bone metastases. The anatomical sites exhibiting the highest level of disagreement between WB-DWIBS and WB-BS are the pelvis, the coccyx, and the sternum, all sites at which detection with WB-BS has the greatest limitations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872462     DOI: 10.1007/s11547-012-0870-2

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  13 in total

1.  Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases.

Authors:  E Balliu; M Boada; I Peláez; J C Vilanova; C Barceló-Vidal; A Rubio; P Galofré; A Castro; S Pedraza
Journal:  Clin Radiol       Date:  2010-09-27       Impact factor: 2.350

2.  Sensitivity and specificity of 3-phase bone scintigraphy in the diagnosis of complex regional pain syndrome of the upper extremity.

Authors:  Nicole Wüppenhorst; Christoph Maier; Jule Frettlöh; Werner Pennekamp; Volkmar Nicolas
Journal:  Clin J Pain       Date:  2010 Mar-Apr       Impact factor: 3.442

Review 3.  Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis.

Authors:  Lian-Ming Wu; Hai-Yan Gu; Jasmine Zheng; Xiao Xu; Lin-Hua Lin; Xia Deng; Wei Zhang; Jian-Rong Xu
Journal:  J Magn Reson Imaging       Date:  2011-05-25       Impact factor: 4.813

4.  Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams.

Authors:  Katsuyuki Nakanishi; Midori Kobayashi; Satoru Takahashi; Saki Nakata; Miyaji Kyakuno; Kazunori Nakaguchi; Hironobu Nakamura
Journal:  Magn Reson Med Sci       Date:  2005       Impact factor: 2.471

5.  Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy.

Authors:  G Cascini; C Falcone; C Greco; B Bertucci; S Cipullo; O Tamburrini
Journal:  Radiol Med       Date:  2008-10-25       Impact factor: 3.469

6.  Whole-body MR imaging: evaluation of patients for metastases.

Authors:  Thomas C Lauenstein; Susanne C Goehde; Christoph U Herborn; Matthias Goyen; Carsten Oberhoff; Jörg F Debatin; Stefan G Ruehm; Jörg Barkhausen
Journal:  Radiology       Date:  2004-08-18       Impact factor: 11.105

7.  Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.

Authors:  Daisuke Takenaka; Yoshiharu Ohno; Keiko Matsumoto; Nobukazu Aoyama; Yumiko Onishi; Hisanobu Koyama; Munenobu Nogami; Takeshi Yoshikawa; Sumiaki Matsumoto; Kazuro Sugimura
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

8.  Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study.

Authors:  A Stecco; G Romano; M Negru; D Volpe; A Saponaro; S Costantino; G Sacchetti; E Inglese; O Alabiso; A Carriero
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

9.  Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.

Authors:  Katsuyuki Nakanishi; Midori Kobayashi; Kazunori Nakaguchi; Miyaji Kyakuno; Nobuyuki Hashimoto; Hiromitsu Onishi; Noboru Maeda; Saki Nakata; Masatomo Kuwabara; Takamichi Murakami; Hironobu Nakamura
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

Review 10.  Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology.

Authors:  Thomas C Kwee; Taro Takahara; Reiji Ochiai; Rutger A J Nievelstein; Peter R Luijten
Journal:  Eur Radiol       Date:  2008-04-30       Impact factor: 5.315

View more
  9 in total

1.  Role of whole-body diffusion-weighted MRI in detecting bone metastasis.

Authors:  Riccardo Del Vescovo; Giulia Frauenfelder; Francesco Giurazza; Claudia Lucia Piccolo; Roberto Luigi Cazzato; Rosario Francesco Grasso; Emiliano Schena; Bruno Beomonte Zobel
Journal:  Radiol Med       Date:  2014-03-18       Impact factor: 3.469

2.  Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis.

Authors:  Motoho Morita; Tetsuya Higuchi; Arifudin Achmad; Azusa Tokue; Yukiko Arisaka; Yoshito Tsushima
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-05       Impact factor: 9.236

3.  Caecal leiomyoma detected by whole-body MRI in a patient with Hodgkin lymphoma: first case report.

Authors:  D Albano; E Sinagra; C Patti; D Narese; A Agrusa; G Di Buono; D Raimondo; M Midiri; R Lagalla; M Galia
Journal:  G Chir       Date:  2017 Jan-Feb

Review 4.  Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.

Authors:  Laura Evangelista; Francesco Bertoldo; Francesco Boccardo; Giario Conti; Ilario Menchi; Francesco Mungai; Umberto Ricardi; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-09       Impact factor: 9.236

5. 

Authors:  Fumio Shimada; Miwa Misawa; Tomio Suzuki
Journal:  CMAJ       Date:  2021-03-15       Impact factor: 8.262

6.  "Superscan" in diffusion-weighted imaging with background body suppression magnetic resonance imaging.

Authors:  Fumio Shimada; Miwa Misawa; Tomio Suzuki
Journal:  CMAJ       Date:  2021-01-11       Impact factor: 8.262

Review 7.  Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques.

Authors:  Rajpaul Attariwala; Wayne Picker
Journal:  J Magn Reson Imaging       Date:  2013-08       Impact factor: 4.813

8.  Whole-body diffusion-weighted imaging with background body signal suppression in the detection of osseous and extra-osseous metastases.

Authors:  Ahmed Abdel Razek; Ahmed Tawfik; Mariam Abdel Rahman; Saleh Teima
Journal:  Pol J Radiol       Date:  2019-11-12

Review 9.  Diagnostic Performance of Diffusion-weighted Magnetic Resonance Imaging in Bone Malignancy: Evidence From a Meta-Analysis.

Authors:  Li-Peng Liu; Long-Biao Cui; Xin-Xin Zhang; Jing Cao; Ning Chang; Xing Tang; Shun Qi; Xiao-Liang Zhang; Hong Yin; Jian Zhang
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.